Artivion | CRY - Assets

Stock Price
38.33
Daily Change
0.33 0.87%
Monthly
-13.50%
Yearly
35.63%
Q1 Forecast
37.14

Artivion reported $857.66M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Accuray USD 456.82M 13.42M Sep/2025
AngioDynamics USD 285.41M 6.14M Feb/2025
Artivion USD 857.66M 19.27M Sep/2025
AtriCure USD 654.18M 18.74M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Inogen USD 307.01M 5.03M Sep/2025
Integra LifeSciences USD 3.65B 21.45M Sep/2025
J&J USD 199.21B 6.39B Dec/2025
Mesa Laboratories USD 434.85M 4.5M Dec/2025
Orthofix International USD 832.61M 4.55M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
ResMed USD 8.5B 195.02M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Surmodics USD 178.56M 1.15M Sep/2024
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 7.87B 496.72M Sep/2025
Terumo JPY 2.26T 362.12B Dec/2025
Trinity Biotech USD 103.71M 4.08M Sep/2025